PRODUCT LITERATURE

Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication :Results From a Multicenter, randomized, Prospective

---

Cilostazol is a new phosphodiesterase inhibitor that suppresses platelet aggregation and also acts as a direct
arterial vasodilator. This prospective, randomized, placebo-controlled, parallel-group clinical trial evaluated the efficacy
of cilostazol for treatment of stable, moderately severe intermittent claudication

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Antiplat

Specific Detail Info

Circulation 1998;98;678-686

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment